Exhibit 1

JOINT FILING AGREEMENT

                 

 The undersigned hereby agree that the Amendment No. 2 to Schedule 13D, dated May 4, 2023, with respect to the common stock of BiomX Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Each of the undersigned agrees to be responsible for the timely filing of this Statement, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

    

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 8th day of May 2023.

 

  By: /s/ Carl L. Gordon  
    Carl L. Gordon  
       
  By: /s/ Erez Chimovits  
    Erez Chimovits  
     
  ORBIMED ISRAEL GP LTD.  
       
  By: /s/ Carl L. Gordon  
    Name: Carl L. Gordon  
    Title: Director  
       
  ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP  
       
  By: ORBIMED ISRAEL GP LTD., its general partner
       
  By: /s/ Carl L. Gordon  
    Name: Carl L. Gordon  
    Title: Director of OrbiMed Israel GP Ltd.